Immunohistochemical expression of BRCA2 protein and allelic loss at theBRCA2 locus in prostate cancer
Stephen M. Edwards(Institute of Cancer Research), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust), Cheryl Gillett(King's College London), Audrey Ardern‐Jones(Royal Marsden NHS Foundation Trust), W.D. Dunsmuir(Guy's Hospital), Catherine M. Corbishley(St George's Hospital), Anna Dowe(Royal Marsden NHS Foundation Trust), D.P. Dearnaley(Royal Marsden NHS Foundation Trust), Roger Kirby(St George's Hospital), Jo A. Kelly(Institute of Cancer Research), Nigel K. Spurr, Diana M. Barnes(Guy's Hospital), Martin E. Young(University of Alabama at Birmingham), CRC BPG UK Fmilial Prostate Cancer(Anstalt für Verbrennungskraftmaschinen List (Austria)), Sunil R. Lakhani(Sullivan Nicolaides Pathology)
International Journal of Cancer
September 25, 1998
Cited by 38
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
The evolutionary history of lethal metastatic prostate cancer
|Nature|2015|1.4k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k